Reliability in one-repetition maximum performance in people with Parkinson’s disease.
This note indexes a cited or audit-added source. It may be an original study, review, guideline, form or methods reference. Treat the specific design and the evidence below as authoritative; a source note is not automatically a primary study.
DOI: 10.1155/2012/928736
Bibliographic record from the original reports
Access labels embedded in these original reference strings are historical. Current access and exact checked components are stated separately below.
Buckley TA, Hass CJ. Reliability in One-Repetition Maximum Performance in People with Parkinson's Disease. Parkinson's Disease. 2012;2012:928736. DOI 10.1155/2012/928736
Conditions: COND-PD Parkinson’s disease
Scoped audit evidence
These are source- and component-level audit summaries as of 3 October 2026. Access and comparison scope can differ by report; none certifies every result or the underlying raw data.
Parkinson’s disease — strength
- access status: full_main_text_available
STR-02-04
STR-02-01
STR-02-02
STR-02-03
Limitations: Only current scoped checks; archived captures not authenticated against live originals.
Parkinson’s disease strength
- current access: full_main_text_available
- primary version: PMC full article; version not independently compared to publisher PDF
Parkinson’s disease strength component — Familiarization and 1RM execution protocol
Methods 2.1–2.3 confirms two familiarization visits, a 10-repetition warm-up, incremental loads, controlled full range, at most five attempts, the same investigator, at least 72 hours between tests, and ON testing 1–1.5 hours after the first dose.
Source locator: PMC full body Methods 2.1–2.3
Limitations: AI-assisted source comparison; no raw-data verification.
Parkinson’s disease strength component — Exercise-specific sample sizes and all Table5 ICC, CI, gain, SEM and calculated MDC values
Methods and Table 2 match the four exercise sample sizes, ICCs, confidence intervals, gains and SEMs. Recalculated MDC 95 values are 15.8, 10.5, 7.8 and 11.9 kg. See audit evidence record.
Source locator: Methods 2.2, Table 2; audit evidence record
Limitations: AI-assisted source comparison; no raw-data verification.
Parkinson’s disease strength component — Retest variability despite familiarization
Results confirms knee-extension extremes of +27 and −27 kg, changes of at least 5 kg in 51%, and significant gains for knee extension, knee flexion and biceps curl. Chest-press gain was nonsignificant.
Source locator: Results paragraph following Table 2, Discussion
Limitations: AI-assisted source comparison; no raw-data verification.
Parkinson’s disease strength component — Protocol omissions and selected-sample feasibility
Full Methods specifies no precise joint-angle settings, load increments or inter-attempt rest. Results says all tests completed without incident; exclusions and absence of dyskinesia/freezing are explicit. Report appropriately avoids universal safety claims.
Source locator: PMC Methods 2.1–2.2 and Results
Limitations: AI-assisted source comparison; no raw-data verification.
Reports citing this source
- Strength muscle power and rapid force production assessment in Parkinson’s disease · reference 2 · original reference
Update record
- 2026-10-03: Created from the supplied reports and final scoped audit. New evidence should be appended with source version, access date, exact locator and affected report links.
Updating the wiki · Evidence and status guide